Client Initiated Sample Clauses

Client Initiated. A UA negotiates the security mechanism to be used with its outbound proxy without knowing beforehand which mechanisms the proxy supports. | | | | | | |<-----(2) 494-------| | | | | |<=======TLS========>| | | | | |----(3) INVITE----->| | | |----(4) INVITE--->| | | | Xxxxx et al [Page 11] INTERNET-DRAFT SIP Sec Agreement May 2002 The UAC sends an OPTIONS request to its outbound proxy, indicating that it is able to negotiate security mechanisms and that it supports TLS and digest-integrity (Step 1 of figure 1). The outbound proxy challenges the UAC with its own list of security mechanisms – IPsec and TLS (Step 2 of figure 1). The only common security mechanism is TLS, so they establish a TLS connection between them (Step 3 of figure 1). When the connection is successfully established, the UAC sends an INVITE over the TLS connection just established (Step 4 of figure 1). This INVITE contains the server’s security list. The server verifies it, and since it matches its static list, it processes the INVITE and forwards it to the next hop. If this example was run without Security-Server header in Step 2, the UAC would not know what kind of security the other one supports, and would be forced to error-prone trials. More seriously, if the Security-verify was omitted in Step 4, the whole process would be prone for MitM attacks. An attacker could spoof "ICMP Port Unreachable" message on the trials, or remove the stronger security option from the header in Step 1, therefore substantially reducing the security. (1) OPTIONS xxxxx.xxxxxxx.xxx Security-Client: tls;q=0.1 Security-Client: digest-integrity;q=0.2 Require: sec-agree (2) 494 (Security Agreement Required) Security-Server: ipsec-ike;q=0.1 Security-Server: tls;q=0.2 (3) INVITE xxxxx.xxxxxxx.xxx Security-Verify: ipsec-ike;q=0.1 Security-Verify: tls;q=0.2 Route: xxxxxx@xxxxxx.xxx The 200 OK response for the INVITE and the ACK are also sent over the TLS connection. The ACK (7) will contain the same Security-Verify header field as the INVITE (3).
Sample 1
AutoNDA by SimpleDocs
Client Initiated. A client wishing to establish some type of security with its first- hop proxy SHOULD add a Security-Client header field to a request addressed to this proxy (i.e., the destination of the request is the first-hop proxy). This header field contains a list of all the security mechanisms that the client supports. The client SHOULD NOT add preference parameters to this list. The client MUST also add a Require header field with the value "sec-agree" to its request. The Security-Client header field is used by the server to include any necessary information in its response. For example, if digest- integrity is the chosen mechanism, the server includes a WWW- Authenticate header in the response. If S/MIME is chosen, the appropriate certificate is included. If the security mechanisms supported by the client do not need any further information to be established (e.g., TLS) the client MAY choose not to include the Security-Client header field in its request. A server receiving a request that contains a Require header field with the value "sec-agree" MUST challenge the client with a 494 (Security Agreement Required) response. The server MUST add a INTERNET-DRAFT SIP Sec Agreement May 2002 Security-Server header field to this response listing the security mechanisms that the server supports. The server MUST add its list to the response even if there are no common security mechanisms in the client's and server's lists. The server’s list MUST NOT depend on the contents of the client's list. The server MUST compare the list received in the Security-Client header field with the list to be sent in the Security-Server header field. When the client receives this response, it will choose the common security mechanism with the higher preference value. Therefore, the server MUST add the necessary information so that the client can initiate that mechanism (e.g., a WWW-Authenticate header field for digest-integrity). When the client receives a response with a Security-Server header field, it SHOULD choose the security mechanism in the server’s list with the highest "q" value among all the mechanisms that are known to the client. Then, it MUST initiate that particular security mechanism as described in Section 3.5. This initiation may be carried out without involving any SIP message exchange (e.g., establishing a TLS connection). All the subsequent SIP requests sent by the client SHOULD make use of the security mechanism initiated in the previous step. These requests MUST contain a ...
Sample 1
Client Initiated. Client, at any time prior to Final Completion, may propose Changes or Extra Work in writing. H&H shall respond by submitting to Client a written proposal containing the estimated cost to perform the Change or Extra Work (including Hard Costs and H&H Fees), annual energy and annual utility, operational and maintenance cost savings, payback period, and a schedule for completion of the Change or Extra Work within fifteen (15) days of Client’s request. H&H shall perform the Changes or Extra Work only upon receipt of Client’s approval of the written proposal. Any Change or Extra Work performed by H&H which is not approved by Client’s Contact in writing shall not be approved for payment and will not be included in the final Scope of Work. The Parties will amend any exhibits affected by the Change and/or Extra Work accordingly.
Sample 1
Client Initiated the end user carries a device that can connect to a gateway device (in most cases over wireless) and support the necessary security procedures but does not require special dedicated software to supported federated access.
Sample 1
Client Initiated. An end user connects to a federation gateway and explicitly signals to that gateway that it wants to access foreign federation services.
Sample 1
Client Initiated a device that can connect to a gateway device (in most cases over wireless) and support the necessary security procedures and requires special dedicated software to support remote federated access (similar to VPN client).
Sample 1
Client Initiated. In the event that Client desires to modify or amend the Statement of Work, Client will work with Xxxxx to initiate a Change Order to Xxxxx noting the general scope, Deliverables, and timeline requirements for the services requested. Xxxxx must timely respond in writing, providing a specific recommendation for the solution, and providing Client with an estimated cost for the work proposed in the Change Order, if applicable. Xxxxx’x written response will include sufficient detail to evaluate the response, including, as appropriate, a breakdown of the number of staff hours, level of personnel needed to effect this change, and technical design information for the proposed solution. If Client elects to move forward with the Change Order, the Change Order shall not become binding until agreed upon by both parties in writing. There is no charge for the preparation of Xxxxx’x response. Client’s submission of an unsolicited Change Order request to Xxxxx does not modify or amend the Statement of Work in any way and creates no Tyler obligations.
Sample 1
AutoNDA by SimpleDocs

Related to Client Initiated

  • Product Testing No later than [**] prior to a scheduled Delivery ARIAD US shall send to ARIAD SWISSCO the Delivery Documents for review. Following such review, unless within [**] of receipt of the Delivery Documents ARIAD SWISSCO gives written notice of rejection of the Product to be delivered, stating the reasons for such rejection, the Delivery shall proceed, and both Parties shall organize the same. Upon arrival at ARIAD SWISSCO nominated site it shall visually inspect the shipment of the Product to identify any damage to the external packaging. ARIAD SWISSCO may reject any shipment (or portion thereof) of the Product that is damaged by providing to ARIAD US reasonable evidence of damage within [**] after Delivery of such Product. If ARIAD SWISSCO does not so reject any shipment (or portion thereof) of the Product within [**] of Delivery of such Product, ARIAD SWISSCO shall be deemed to have accepted such shipment of the Product; provided, however, that in the case of the Product having any Latent Defect, ARIAD SWISSCO shall notify ARIAD US promptly once it becomes aware that a Product contains a Latent Defect and subsequently may reject such Product by giving written notice to ARIAD US of ARIAD SWISSCO’s rejection of such Product and shipping a representative sample of such Product or other evidence of Non-Conformance to ARIAD US within [**] after becoming aware of such Latent Defect, which notice shall include a description of the Latent Defect.

  • Training a. The employer, in consultation with the local, shall be responsible for developing and implementing an ongoing harassment and sexual harassment awareness program for all employees. Where a program currently exists and meets the criteria listed in this agreement, such a program shall be deemed to satisfy the provisions of this article. This awareness program shall initially be for all employees and shall be scheduled at least once annually for all new employees to attend. b. The awareness program shall include but not be limited to: i. the definitions of harassment and sexual harassment as outlined in this Agreement; ii. understanding situations that are not harassment or sexual harassment, including the exercise of an employer's managerial and/or supervisory rights and responsibilities; iii. developing an awareness of behaviour that is illegal and/or inappropriate; iv. outlining strategies to prevent harassment and sexual harassment; v. a review of the resolution of harassment and sexual harassment as outlined in this Agreement; vi. understanding malicious complaints and the consequences of such; vii. outlining any Board policy for dealing with harassment and sexual harassment; viii. outlining laws dealing with harassment and sexual harassment which apply to employees in B.C.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Emergency Escalation initiated by ICANN Upon reaching 10% of the Emergency thresholds as described in Section 6 of this Specification, ICANN’s emergency operations will initiate an Emergency Escalation with the relevant Registry Operator. An Emergency Escalation consists of the following minimum elements: electronic (i.e., email or SMS) and/or voice contact notification to the Registry Operator’s emergency operations department with detailed information concerning the issue being escalated, including evidence of monitoring failures, cooperative trouble-­‐shooting of the monitoring failure between ICANN staff and the Registry Operator, and the commitment to begin the process of rectifying issues with either the monitoring service or the service being monitoring.

  • Screening After you sign and date the consent document, you will begin screening. The purpose of the screening is to find out if you meet all of the requirements to take part in the study. Procedures that will be completed during the study (including screening) are described below. If you do not meet the requirements, you will not be able to take part in the study. The study investigator or study staff will explain why. As part of screening, you must complete all of the items listed below: • Give your race, age, gender, and ethnicity • Give your medical history o You must review and confirm the information in your medical history questionnaire • Give your drug, alcohol, and tobacco use history • Give your past and current medication and treatment history. This includes any over-the-counter or prescription drugs, such as vitamins, dietary supplements, or herbal supplements, taken in the past 28 days • Height and weight will be measured • Physical exam will be done • Electrocardiogram (ECG) will be collected. An ECG measures the electrical activity of the heart • You may be tested for COVID-19 o Blood tests for human immunodeficiency virus (HIV), hepatitis B, and hepatitis C o Blood tests to see how your blood clots ▪ Fibrinogen ▪ PT/INR/aPTT o Blood tests for amylase and lipase (enzymes that help with digestion, Part B only) o Blood tests for a lipid (fats) panel (Part B only) ▪ Total cholesterol ▪ Triglycerides ▪ HDL ▪ Direct HDL o Blood tests to check your thyroid function (Part B and Part C only) ▪ TSH ▪ Free T4 o Urine to test for drugs of abuse (illegal and prescription) o Urine tests to check your albumin/ creatinine ratio o Females who have not had a period for at least 12 months in a row will have a blood hormone test to confirm they cannot have children • The study investigator may decide to do an alcohol breath test • The use of proper birth control will be reviewed (males only) • You will be asked “How do you feel?” HIV, hepatitis B, and hepatitis C will be tested at screening. If anyone is exposed to your blood during the study, you will have these tests done again. If you have a positive test, you cannot be in or remain in the study. HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). If your HIV test is positive, you will be told about the results. It may take weeks or months after being infected with HIV for the test to be positive. The HIV test is not always right. Having certain infections or positive test results may have to be reported to the State Department of Health. This includes results for HIV, hepatitis, and other infections. If you have any questions about what information is required to be reported, please ask the study investigator or study staff. Although this testing is meant to be private, complete privacy cannot be guaranteed. For example, it is possible for a court of law to get health or study records without your permission.

  • Research Support (a) Having regard to the resources reasonably available for such purposes, the Operator will cooperate with AHS to provide such participation by its Staff as may be reasonable in relation to the carrying out of research within the Province. (b) The Operator agrees to promptly notify AHS in the event that it undertakes or agrees to participate in any form of clinical trial, research project, instrument use, or similar activity which in any way relates to the Services provided under this Agreement. The Operator shall, upon request, provide AHS with written evidence of Client disclosure and consent to research.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Innovative Scheduling Schedules which are inconsistent with the Collective Agreement provisions may be developed in order to improve quality of working life, support continuity of resident care, ensure adequate staffing resources, and support cost-efficiency. The parties agree that such innovative schedules may be determined locally by the Home and the Union subject to the following principles: (a) Such schedules shall be established by mutual agreement of the Home and the Union; (b) These schedules may pertain to full-time and/or part-time employees; (c) The introduction of such schedules and trial periods, if any, shall be determined by the local parties. Such schedules may be discontinued by either party with notice as determined through local negotiations; (d) Upon written agreement of the Home and the Union, the parties may agree to amend collective agreement provisions to accommodate any innovative unit schedules; (e) It is understood and agreed that these arrangements are based on individual circumstances and each agreement is made on a without prejudice or precedent basis. (f) It is understood and agreed that these arrangements can be utilized for temporary job postings for seasonal coverage (e.g. weekend workers, etc.).

  • Contracted Services PPG and Member Physicians shall render Contracted Services which are not PPG Capitated Services to Members covered under this Addendum B and shall be compensated on a fee-for-service basis at the rates set forth in Addendum E. PPG shall submit claims in accordance with the terms of this Agreement and State and federal law.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!